Metagenomi to Present at Upcoming Scientific Meetings

- Oral Presentation at World Federation of Hemophilia (WFH) World Congress, April 23, 2024 - Two Posters at American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, May 8 & 9, 2024 EMERYVILLE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today announced that the Company will prese

Related Keywords

Spain ,Madrid , ,Nasdaq ,American Society Of Gene Cell Therapy ,Metagenomi Inc ,Oral Presentation At World Federation Of Hemophilia ,World Federation Of Hemophilia ,World Congress ,World Federation ,American Society ,Cell Therapy ,Presentation Title ,Curative Gene Editing Approach ,Reverse Transcriptases Discovered ,Metagenomics Enable Extensive Remodeling ,Efficient Base Editors Engineered ,Comprehensively Target ,Note Regarding Forward ,Exchange Act ,Reform Act ,Metagenomi ,Nc ,Abstract Number ,American Society Of Gene ,Baltimore ,D ,